Beam Therapeutics (BEAM) Research & Development: 2019-2025
Historic Research & Development for Beam Therapeutics (BEAM) over the last 7 years, with Sep 2025 value amounting to $109.8 million.
- Beam Therapeutics' Research & Development rose 16.46% to $109.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $411.8 million, marking a year-over-year increase of 1.38%. This contributed to the annual value of $367.6 million for FY2024, which is 15.96% down from last year.
- Beam Therapeutics' Research & Development amounted to $109.8 million in Q3 2025, which was up 7.87% from $101.8 million recorded in Q2 2025.
- Over the past 5 years, Beam Therapeutics' Research & Development peaked at $190.1 million during Q1 2021, and registered a low of $45.6 million during Q2 2021.
- Its 3-year average for Research & Development is $101.4 million, with a median of $99.6 million in 2023.
- Its Research & Development has fluctuated over the past 5 years, first spiked by 782.20% in 2021, then plummeted by 65.59% in 2022.
- Beam Therapeutics' Research & Development (Quarterly) stood at $96.8 million in 2021, then dropped by 10.79% to $86.3 million in 2022, then spiked by 62.24% to $140.1 million in 2023, then declined by 27.58% to $101.4 million in 2024, then rose by 16.46% to $109.8 million in 2025.
- Its Research & Development stands at $109.8 million for Q3 2025, versus $101.8 million for Q2 2025 and $98.8 million for Q1 2025.